Megan McNally, MD
Surgery · Lees Summit, MONPI 1598781692
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,900 of the $7,213 with a category attached, or 67.9%. Davol Inc. accounts for 79.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $3,300 and has fallen 95.8% since, to $139 in 2025.
Across 14 payments — averaging $515.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Davol Inc.$6K
- Applied Medical Resources Corporation$888
- Intuitive Surgical$284
- W. L. Gore & Associates, Inc.$141
- Histosonics, Inc.$139
- LSI Solutions Inc$39
- plus $23 from 1 others
What the payments were for
- Consulting fees$80011%
- Speaking & faculty fees$4,90068%
- Travel & lodging$84512%
- Food & beverage$6699%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Davol Inc. | 3 | $5,700 |
| Applied Medical Resources Corporation | 3 | $888 |
| Intuitive Surgical | 3 | $284 |
| W. L. Gore & Associates, Inc. | 2 | $141 |
| Histosonics, Inc. | 1 | $139 |
| LSI Solutions Inc | 1 | $39 |
| Merck | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,213 in reported general payments places this provider in the 75th percentile of 612 surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 45 | $260 |
| Metronidazole | 51 | $151 |
| Cephalexin | 14 | $64 |
| Oxycodone Hcl | 26 | $58 |
| Tramadol Hcl | 47 | $54 |
| Promethazine Hcl | 36 | $53 |
Paid to pharmacies, not to this prescriber.
Other surgery in Lees Summit
- Jonathan WilsonLees Summit$21K
- James ScottSaint Louis$307K
- Omar GuerraSaint Louis$249K
- John TannColumbia$216K
- Mark DrakeSaint Louis$212K
- Adeel KhanSaint Louis$204K
- Michael AwadSaint Louis$176K
- Patricia HodginsFenton$145K
- Laurie PunchSaint Louis$141K
- Jeffrey BlatnikSaint Louis$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.